The HCA Healthcare Inc (HCA) share price is expected to increase by 17.97% over the next year. This is based on calculating the average 12-month share price estimate provided by 22 stock analysts who have covered HCA. Price targets range from $359 at the low end to $460 at the high end. The current analyst consensus for HCA is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
HCA is a stock in Healthcare which has been forecasted to be worth $411.41 as an average. On the higher end, the forecast price is $460 USD by from and on the lower end HCA is forecasted to be $359 by Pito Chickering from Deutsche Bank.
These are the latest 20 analyst ratings of HCA.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Stephen Baxter Wells Fargo | Equal-Weight | $400 | Maintains | Nov 6, 2024 |
Michael Wiederhorn Oppenheimer | Outperform | $400 | Maintains | Oct 28, 2024 |
Gary Taylor TD Cowen | Buy | $440 | Maintains | Oct 28, 2024 |
Matthew Gillmor Keybanc | Overweight | $420 | Maintains | Oct 28, 2024 |
Stephen Baxter Wells Fargo | Equal-Weight | $395 | Maintains | Oct 22, 2024 |
Matthew Gillmor Keybanc | Overweight | $475 | Initiates | Oct 11, 2024 |
Sarah James Cantor Fitzgerald | Overweight | $392 | Reiterates | Oct 4, 2024 |
Sarah James Cantor Fitzgerald | Overweight | $392 | Reiterates | Oct 1, 2024 |
Craig Hettenbach Morgan Stanley | Equal-Weight | $427 | Initiates | Sep 3, 2024 |
Ben Hendrix RBC Capital | Outperform | $405 | Maintains | Aug 23, 2024 |
Sarah James Cantor Fitzgerald | Overweight | $392 | Reiterates | Aug 20, 2024 |
David Macdonald Truist Securities | Buy | $430 | Maintains | Aug 19, 2024 |
Sarah James Cantor Fitzgerald | Overweight | $392 | Reiterates | Aug 19, 2024 |
Andrew Mok UBS | Buy | $438 | Maintains | Aug 14, 2024 |
Stephen Baxter Wells Fargo | Equal-Weight | $365 | Maintains | Jul 30, 2024 |
Sarah James Cantor Fitzgerald | Overweight | $392 | Maintains | Jul 25, 2024 |
Andrew Mok Barclays | Overweight | $396 | Maintains | Jul 24, 2024 |
Michael Wiederhorn Oppenheimer | Outperform | $390 | Maintains | Jul 24, 2024 |
Leerink Partners | Outperform | $396 | Maintains | Jul 24, 2024 |
Sarah James Cantor Fitzgerald | Overweight | $335 | Reiterates | Jul 24, 2024 |
When did it IPO
2011
Staff Count
220,000
Country
United States
Sector/Industry
Healthcare/Medical Care Facilities
CEO
Mr. Samuel N. Hazen
Market Cap
$92.87B
In 2023, HCA generated $64.97B in revenue, which was a increase of 7.86% from the previous year. This can be seen as a signal that HCA's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Investors express concern over potential impacts on hospital operators and vaccine makers under a Trump administration, while showing optimism for Medicare Advantage plan providers.
Why It Matters - Concerns over regulatory shifts under a Trump administration could impact hospital operators and vaccine makers, while optimism for Medicare Advantage plans suggests potential growth in that sector.
Summary - HCA Healthcare (NYSE: HCA), the third-largest U.S. healthcare provider, has seen its shares decline over 13% since reaching an all-time high on October 18.
Why It Matters - HCA's recent 13% drop from its all-time high may indicate volatility in the healthcare sector, potentially affecting investor sentiment and future performance outlook.
Summary - HCA is expected to gain from increased volume growth and ongoing expansion initiatives.
Why It Matters - HCA's anticipated volume growth and expansion could lead to increased revenues and market share, positively impacting its stock performance and overall financial health.
Summary - HCA Healthcare surpassed Wall Street profit estimates due to higher hospital admissions and lower labor costs in the latest quarterly results.
Why It Matters - HCA Healthcareโs earnings beat signals strong operational efficiency and demand, potentially boosting investor confidence and stock performance in the healthcare sector.
Summary - HCA Healthcare (HCA) announced that recent hurricanes will negatively affect its results, leading to a roughly 10% decline in shares on Friday afternoon.
Why It Matters - HCA Healthcare's forecasted losses from recent hurricanes indicate potential revenue declines, leading to a significant share price drop, which affects investor confidence and portfolio performance.
Summary - HCA stock fell after missing Q3 estimates, attributing the shortfall to hurricanes and providing a subdued outlook, raising concerns for investors.
Why It Matters - HCA's Q3 miss signals operational challenges and potential ongoing impacts from external factors, raising concerns about future performance and profitability, which can affect stock value.